At the IGTP TODAY
The Fisabio Foundation, an organisation under the Department of Health, and IGTP have signed a framework agreement for scientific collaboration to jointly promote research in the field of AI and radiomics
The demonstration of the vaccine's efficacy in its preclinical phase was carried out at the Comparative Medicine and Bioimage Centre of Catalonia, a trategic project of IGTP.
IGTP strengthens its commitment to excellence in innovation management and consolidates its position as a leading research centre with the attainment of the international ISO 56001 certification. This milestone recognises the implementation of a consolidated innovation management system aligned with international standards.
A clinical trial involving 40 patients, led by IrsiCaixa and IGTP and conducted at HUGTiP, confirms that the RUTI® vaccine, owned by Archivel Farma, enhances the effectiveness of the current treatment for non-muscle-invasive bladder cancer.
A study led by GCAT-IGTP links the VEGFA protein to long COVID, especially in postmenopausal women, suggesting a vascular mechanism behind persistent symptoms. The findings highlight the need to consider sex and hormonal status in long COVID research and treatment.
CEEISCAT and the Grupo de Trabajo sobre Tratamientos del VIH (gTt-VIH) announce the start of data collection for the SEXPROM Study, a pioneering investigation in Spain that will explore sexual satisfaction among people living with HIV, with a differentiated focus by gender and sexual orientation.
The combination of the drug nivolumab with chemotherapy improves survival in patients with high-risk head and neck cancer and could become the new standard treatment, according to the results of an international trial led by professionals from ICO, IGTP and IDIBELL.
A study coordinated from Badalona by IrsiCaixa, the Catalan Institute of Oncology and the Germans Trias i Pujol Research Institute (within the CARE programme) has identified KIMA, a genomic signature that makes it possible to anticipate which patients with HR+/HER2- breast cancer will respond less well to CDK4/6 inhibitors. The finding, published in the journal Clinical and Translational Medicine, may help personalize therapies and design new combinations.
The "la Caixa" Foundation has announced the results of the 2025 call for proposals for its CaixaImpulse program, through which it supports 31 biomedical projects from research centres, hospitals and universities in Spain and Portugal. A project coordinated by IIS IGTP led by Ana Piqueras (HUGTiP) has been selected in the call to continue with the development and implementation of a medical device to find and remove cancer cells more accurately during surgery.
On 18 September, around thirty people involved in the Innomed program visited the Werfen facilities in Lliçà d'Amunt (the Immunoassay Technology Center). The meeting provided an opportunity to learn about the company's strategic areas and to establish contacts for exploring possible collaborations.
